Hua-feng Kang Selected Research

Scutellaria barbata extract

10/2008	[Antitumor and immune-modulating effects of Scutellaria barbata extract in mice bearing hepatocarcinoma H22 cells-derived tumor].
8/2008	[Effects of Scutellaria Barbata drug-containing serum on apoptosis and mitochondrial transmembrane potential of hepatoma H22 cells].
7/2008	[Scutellaria barbata extract enhances efficacy and reduces toxicity of chemotherapy in hepatoma H22-bearing mice].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hua-feng Kang Research Topics

Disease

2	Carcinoma (Carcinomatosis) 05/2009 - 07/2007
2	Neoplasms (Cancer) 10/2008 - 07/2008
2	Body Weight (Weight, Body) 10/2008 - 07/2008
2	Hepatocellular Carcinoma (Hepatoma) 08/2008 - 07/2008
2	Breast Neoplasms (Breast Cancer) 09/2007 - 11/2006
1	Inflammation (Inflammations) 05/2009
1	Liver Neoplasms (Liver Cancer) 08/2008
1	Anorexia 07/2008
1	Alopecia (Baldness) 09/2007
1	Thrombocytopenia (Thrombopenia) 09/2007
1	Neoplasm Metastasis (Metastasis) 07/2007

Drug/Important Bio-Agent (IBA)

3	Scutellaria barbata extractIBA 10/2008 - 07/2008
2	MatrinesIBA 05/2009 - 07/2007
1	AlkaloidsIBA 05/2009
1	Caspase 3 (Caspase-3)IBA 05/2009
1	Interleukin-2 (IL2)IBA 10/2008
1	Pharmaceutical PreparationsIBA 08/2008
1	Fluorouracil (Carac)FDA LinkGeneric 07/2008
1	Therapeutic UsesIBA 07/2008
1	Hemoglobins (Hemoglobin)IBA 09/2007
1	Tamoxifen FDA LinkGeneric 11/2006
1	anthraceneIBA 11/2006
1	Celecoxib (Celebrex)FDA Link 11/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2006

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 07/2008
1	CMF regimen 09/2007
1	Neoadjuvant Therapy 09/2007
1	Injections 07/2007